Insider Transactions in Q1 2024 at Clover Health Investments, Corp. (CLOV)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,168
-0.52%
|
$0
$0.8 P/Share
|
|
Mar 15
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
5,378
-0.22%
|
$0
$0.8 P/Share
|
|
Mar 14
2024
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
74,396
-2.48%
|
$0
$0.73 P/Share
|
|
Mar 14
2024
|
Anna U Loengard Director |
BUY
Open market or private purchase
|
Indirect |
13,625
+47.39%
|
$0
$0.73 P/Share
|
|
Mar 14
2024
|
Anna U Loengard Director |
BUY
Open market or private purchase
|
Direct |
137,000
+20.27%
|
$0
$0.73 P/Share
|
|
Mar 14
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
7,777
-0.31%
|
$0
$0.73 P/Share
|
|
Feb 14
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,020
-0.6%
|
$0
$0.95 P/Share
|
|
Feb 09
2024
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
8,266
-0.46%
|
$8,266
$1.02 P/Share
|
|
Feb 08
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,367
-0.78%
|
$85,367
$1.0 P/Share
|
|
Jan 25
2024
|
Scott J. Leffler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83,538
-1.69%
|
$0
$0.98 P/Share
|
|
Jan 18
2024
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
38,030
-1.93%
|
$0
$0.98 P/Share
|
|
Jan 07
2024
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,561,065
-100.0%
|
$0
$0.95 P/Share
|
|
Jan 07
2024
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,561,065
+50.0%
|
-
|
|
Jan 07
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
16,369
-0.65%
|
$0
$0.95 P/Share
|
|
Jan 07
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,862
-0.39%
|
$0
$0.95 P/Share
|
|
Jan 03
2024
|
Chelsea Clinton Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+27.56%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Anna U Loengard Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+33.91%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+33.34%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
William G Robinson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+31.06%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Lee Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+27.72%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
206,185
+30.69%
|
$0
$0.97 P/Share
|
|
Jan 03
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
26,240
-1.04%
|
$0
$0.92 P/Share
|
|
Jan 01
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
1,559
-0.06%
|
$0
$0.95 P/Share
|
|
Jan 01
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084,906
-8.99%
|
$0
$0.95 P/Share
|